Quantitative measurement of (219)Rn radioactivity in exhaled breath from patients with bone metastasis of castration-resistant prostate cancer treated with (223)RaCl(2)

BACKGROUND: The α-emitting radionuclide radium-223 ((223)Ra) is widely used for the treatment of bone metastasis in patients with castration-resistant prostate cancer. However, (223)Ra decays into radon-219 ((219)Rn) which is a noble-gas isotope, and (219)Rn may escape from patients treated with (22...

Descripción completa

Detalles Bibliográficos
Autores principales: Ooe, Kazuhiro, Watabe, Tadashi, Kamiya, Takashi, Yoshimura, Takashi, Hosono, Makoto, Shinohara, Atsushi, Hatazawa, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660527/
https://www.ncbi.nlm.nih.gov/pubmed/31350633
http://dx.doi.org/10.1186/s40658-019-0249-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660527/
https://www.ncbi.nlm.nih.gov/pubmed/31350633
http://dx.doi.org/10.1186/s40658-019-0249-8

Ejemplares similares